Levoleucovorin
- Generic Name
- Levoleucovorin
- Brand Names
- Fusilev, Khapzory
- Drug Type
- Small Molecule
- Chemical Formula
- C20H23N7O7
- CAS Number
- 68538-85-2
- Unique Ingredient Identifier
- 990S25980Y
- Background
Levoleucovorin is the enantiomerically active form of Folinic Acid (also known as 5-formyl tetrahydrofolic acid or leucovorin). Commercially available leucovorin is composed of a 1:1 racemic mixture of the dextrorotary and levorotary isomers, while levoleucovorin contains only the pharmacologically active levo-isomer. In vitro, the levo-isomer has been shown...
- Indication
Levoleucovorin is indicated for use as rescue therapy following high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA, dosed at one-half the usual dose of racemic d,l-leucovorin), has an additional indication for use...
- Associated Conditions
- Advanced Colorectal Cancer, Folic acid antagonist overdose, Metastatic Colorectal Cancer (CRC)
- Associated Therapies
- Rescue after high-dose methotrexate therapy in osteosarcoma therapy
Overcoming obstacles in personalised medicine
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.